Mike, I've been going back over Avant Diagnostics 10K for the FY ending 2016 which is the most recent 10K submitted to the SEC. There is discussion throughout the report of OvaDx especially on pages 6,17,&18 and on the financial statements on page F-20. Strangely, although the report is for FY16, there are many entries made reflecting actions as recent as June 2018...especially with regard to key personnel changes. I was hoping to find something to clarify the current relationship between Avant and Arrayit concerning OvaDx but to no avail. Theralink is the only test that Avant shows on its web page now...where it used to feature OvaDx.
Market Data 
Markets 
AI
